Epi-on or epi-off? Accelerated or not? A review from Nikki Hafezi and Farhad Hafezi on the current state of the art for CXL treatment of progressive keratoconus
Zurich, Switzerland. A new study by the research group of Prof. Farhad Hafezi may open new alleys for the treatment of very thin keratoconic corneas in the future
Keratoconus treatment by cross-linking in children and adolescents, at the ELZA Institute (article in German)
Gathering of Ocular Surface Specialists at the Annual MCLOSA Meeting in London. With talks on Stevens Johnson Syndrome, keratoconus, cross-linking, DMEK and other topics
The British journal “The Ophthalmologist” reports on our recent success in translating CXL technology into the mouse eye
Light for Sight is uniting clinical institutions, research groups, patient organizations
L4S21 aims to reduce severe visual impairment among children and adolescents with Down Syndrome
Irregular astigmatism knows various underlying causes, including previous complicated eye surgery, and diseases like keratoconus.
Myopia is a growing concern on a global level. In certain areas of Asia, up to 90% of school children are affected. In Japan, progressive myopia represents the third leading cause of blindness.
Summary of a presentation about PACK-Crosslinking given at the 2015 EUCornea meeting.
